New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareMazdutide vs Somatropin (HGH)

Mazdutide vs Somatropin (HGH)

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Mazdutide
Growth Hormone PeptidesAnti-Aging & Longevity
Somatropin (HGH)
Summary
Mazdutide is a once-weekly GLP-1/glucagon dual receptor agonist developed by Innovent Biologics and Eli Lilly. Phase 2 trials in Chinese populations demonstrated up to 11.3% body weight reduction at 6 mg over 24 weeks. It also improves liver fat, glycemic control, and lipid profiles. Phase 3 trials are ongoing primarily in China.
Somatropin is recombinant human growth hormone (rhGH), identical in structure to the 191-amino acid pituitary-derived growth hormone. It is FDA-approved for growth hormone deficiency, short stature, and wasting conditions. Off-label, it is widely explored for body composition, anti-aging, and performance enhancement, though significant risks accompany unsupervised use.
Half-Life
~7 days
2-3 hours (subcutaneous); 20-30 minutes (intravenous)
Admin Route
SubQ
Subcutaneous, Intramuscular (less common)
Research
Typical Dose
1.5 mg → 3 mg → 4.5 mg → 6 mg
0.15-0.3 mg/day (adults); titrated to IGF-1 levels
Frequency
Once weekly
Once daily
Key Benefits
  • Up to 11.3% body weight reduction at 24 weeks (Phase 2, 6 mg dose)
  • Significant reduction in liver fat content (NAFLD/MASH potential)
  • Improves HbA1c and fasting glucose in type 2 diabetes
  • Favorable lipid profile changes (reduced triglycerides)
  • Once-weekly subcutaneous dosing
  • Potential for superior weight loss vs GLP-1 monotherapy
  • Increases lean muscle mass and reduces body fat (particularly visceral)
  • Restores growth hormone deficiency (FDA-approved)
  • Improves bone mineral density
  • Enhances exercise capacity and recovery
  • Supports skin thickness and collagen synthesis
  • Improves lipid profile in GHD patients
  • Explored for anti-aging and cellular regeneration
Side Effects
  • Nausea
  • Vomiting
  • Decreased appetite
  • Diarrhea
  • +3 more
  • Fluid retention and edema (common, dose-dependent)
  • Carpal tunnel syndrome
  • Joint and muscle pain
  • Insulin resistance and elevated blood glucose
  • +3 more
Stacks With